Company
Cellbricks Therapeutics
Human Tissue Therapeutics
Also known as Cellbricks, Cellbricks GmbH
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Berlin, Germany
- Legal name
- Cellbricks GmbH
- cellbricks-therapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Cellbricks Therapeutics is a Berlin and Boston-based preclinical biotech company pioneering the future of regenerative medicine and longevity. Built on deep tech innovation, the company combines proprietary biofabrication technology with advanced biomaterials and human cells to develop implantable tissue grafts for clinical use. Cellbricks’ mission is to transform healthcare by restoring tissue function – reliably and at scale.
Funding snapshot
- Latest round
- Undisclosed2026-03-25
Funding rounds
- Round, 2026
- 2026-03-25
Products
- Other
- Tissue Therapeutics
Loading relationship preview